TIOVA is indicated for the long-term, once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
The recommended dosage of TIOVA is one Rotacap inhaled once daily, using the Cipla Rotahaler/ Revolizer.
No dosage adjustment is required for geriatric, hepatically-impaired, or renally-impaired patients. However, patients with moderate to severe renal impairment, who are being treated with TIOVA should be monitored closely.
TIOVA are for inhalation only and must not be swallowed.
TIOVA Rotacaps .......... pack contains 15 rotacaps